Maria Epstein, MD
Family Medicine · Orlando, FLNPI 1457714818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $209 and has fallen 71.2% since, to $60 in 2024. That places this record below the midpoint for family medicine clinicians in FL, where the typical reported total is $424.
Across 30 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$57
- GSK$52
- Pfizer$29
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
- Amgen$28
- Daiichi Sankyo Inc.$27
- plus $217 from 12 others
What the payments were for
- Food & beverage$438100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 4 | $57 |
| GSK | 3 | $52 |
| Pfizer | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Amgen | 2 | $28 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Novartis | 2 | $25 |
| Abbott | 1 | $25 |
| Amarin Pharma, Inc. | 2 | $24 |
| Novo Nordisk | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Mannkind Corporation | 1 | $14 |
| Qiagen, LLC | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
How this compares
$438 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 11 | $146 |
| Losartan Potassium | 13 | $88 |
| Atorvastatin Calcium | 13 | $51 |
| Amlodipine Besylate | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Orlando
- Richard LappOrlando$702K
- Asim RahmanOrlando$124K
- Arilda MargjoniOrlando$71K
- Rafael PineroOrlando$61K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.